Arizona Pharmacy Flash
Oct. 23, 2012

Fungal Meningitis Outbreak
Food and Drug Administration
The Food and Drug Administration is making available two lists of customers (consignees) who received products that were shipped on or after May 21 from New England Compounding Center's Framingham, Mass., facility. The first list includes customer names and addresses, organized by state. The second list contains the same basic information as the first list, but is organized alphabetically by customer name and also includes the specific products shipped, the quantities of product shipped, and the shipping date. The lists were prepared based on information provided by NECC, and FDA cannot vouch for the completeness or accuracy of the lists. Products shipped by NECC may be missing from the list and facility information may be incomplete. Nevertheless, this is the best information we have available, at this time, to help inform facilities and healthcare providers of NECC products shipped to their facilities since May 21.More

National Pharmacy Technician Day
AzPA
Oct. 23 is National Pharmacy Technician Day. National Pharmacy Technician Day highlights the important role pharmacy technicians play in supporting pharmacists in the delivery of safe and effective patient care. More

Pharmacy-Based Immunization Services Certificate Training Program
AzPA
Date: Monday, Nov. 12
Early Registration deadline is October 29.
Only 8 spots left. Click to register. More

Congratulations to AzPA member Ken Fletcher
AzPA
Congratulations to AzPA member Ken Fletcher, Pharm.D., Thatcher, Ariz., with Safeway, on being selected as a finalist in the 2012 Next Generation Awards presented by Pharmacy Times and Parata. Fletcher was nominated in the Civic Leader of the Year category for his service as the AzPA Southeast District Director and his efforts to educate health care providers in his district on the importance of reporting through the Arizona State Board of Pharmacy Controlled Substances Prescription Drug Monitoring Program.More

Holiday shopping is upon us
AzPA
Remember to purchase your gift cards through AzPA and support pharmacy education in Arizona. Learn more.More

Shop Amazon.com and support AzPA
AzPA
The next time you shop on Amazon.com, visit the AzPA website first and click on the portal on the home page. When you enter through the AzPA website, a portion of your total purchases will come back to AzPA. Bookmark this link.More

Not an AzPA member? Join today
AzPA
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry.More

Meningitis toll rises; pharmacy owners sued
Reuters
Executives at the Boston-area pharmacy whose steroid shots have been linked to a deadly meningitis outbreak have been sued in a bid to freeze their personal assets, while the death toll and reported infections continue to rise. Peter McGrath, a lawyer who is a former federal prosecutor, said he was spearheading a civil case that blames Massachusetts-based New England Compounding Center and company officers Barry and Lisa Cadden and Greg Conigliaro for the tainted drugs. The lawsuit was filed on behalf of an unnamed plaintiff in Middlesex County Superior Court in suburban Boston, court records show.More

Pharmacist telemonitoring improves blood pressure management
Pharmacy Times
Telemonitoring by pharmacist case managers appears to be a viable method of improving blood pressure control in patients with hypertension, according to the results of a study published in the recent edition of the Journal of Clinical Hypertension. In particular, researchers noted that patients in the telemonitoring group that checked in with pharmacist case managers were particularly compliant with self-monitoring procedures.More

FDA raises awareness of fake pharmacies with 'BeSafeRX'
The Legal Examiner
Have you bought a medical prescription drug online recently? If so, you were at a high risk of being scammed. According to the National Association of Boards of Pharmacy, less than three percent of online pharmacies meet state and federal laws. That means 97 percent are either breaking the law or operating outside the codes of proper practice. Fortunately, the FDA has launched a new national campaign to raise awareness of the issue, and help consumers to determine which sites are legitimate.More

FDA nod for Bristol-Myers Squibb drug label update
NASDAQ
Bristol-Myers Squibb Company recently announced that the Food and Drug Administration has cleared a label update for its hepatitis B virus therapy, Baraclude. The FDA has allowed Bristol-Myers to update Baraclude's label so that data on African-Americans and liver transplant recipients suffering from HBV may be included.More

Anti-psychotic drug prescription should lessen for people with dementia
Medical News Today
The challenge of reducing the usage of anti-psychotic drugs among dementia patients proves to be more difficult than originally estimated. This has become a vital public health issue in the U.K., because these drugs are associated with up to 1,800 deaths a year in people with dementia. The actual usage of anti-psychotic drugs in dementia patients may be up to 46 percent more than any original numbers suggests.More

Pharmacies say Methcheck system is working
WLNS-TV
After another case of meth abuse in Jackson County, Mich., officials from the Tri-county Metro Narcotics Squad say meth labs are popping up because it's now easier to make. Pharmacies however say it's not because the supplies are easier to purchase. Thanks to the federal Combat Methamphetamine Epidemic Act, buying and abusing products like Sudafed and other cold medicines have become more difficult over the last few years.More

Jetrea approved to treat eye condition
HealthDay
Jetrea has been approved by the Food and Drug Administration to treat an eye condition called symptomatic vitreomacular adhesion. Jetrea helps break down proteins that are responsible for VMA, preventing the need for surgery to control the condition, the agency said.More

FDA panel recommends GI drug
MedPage Today (free subscription)
An FDA panel voted unanimously to recommend approval of a drug to help patients who have lost the ability to absorb nutrients, despite the agency's concerns over the manufacturer's risk-management plan. The 12-0 vote to recommend approval of teduglutide to treat short bowel syndrome came even though FDA reviewers raised doubts about the strength of the proposed plan to monitor the drug's safety and use after approval. Members of the FDA's Gastrointestinal Drugs Advisory Committee appeared not to share those same concerns.More

FDA review raises safety concerns about mipomersen
Forbes
An FDA review raises a number of potentially significant safety concerns about the cholesterol-lowering drug mipomersen. The review appeared ahead of a recent meeting of the Endocrinologic and Metabolic Drugs Advisory Committee to evaluate Genzyme's new drug application for use of the drug as an adjunct to maximally tolerated lipid-lowering medications and diet to reduce LDL, apolipoprotein B, total cholesterol, non-high density lipoprotein-cholesterol and lipoprotein(a) in patients with homozygous familial hypercholesterolemia. Mipomersen is an antisense oligonucleotide inhibitor which targets apoB-100. More

Abraxane approved to treat advanced lung cancer
HealthDay
Abraxane has been approved by the Food and Drug Administration — in combination with the drug carboplatin — to treat advanced or spreading non-small cell lung cancer among people who aren't candidates for surgery or radiation therapy, the agency recently said. Abraxane was first approved in 2005 to treat breast cancer.More